This project is sponsored by National Science Fund, Ministry of Education and Science
About the project
- Project Description and Research Programme
- Status of the Scientific Investigations in the Respective Research Field in Bulgaria
- Up-to-date Status of the Scientific Issues in Bulgaria and Europe
- Description of the Beneficiary University or Department
- Description of the Project Working Program
- Establishment of Beneficial Environment for Young Researchers
- Plan for Stable Activities of the Center after the End of the Project
- Plan for Results Dissemination
Work programme
- WP1 - Collection and Storage of Clinical Samples. Biobank;
- WP2 - In-cell and Immunological Biomarkers;
- WP3 - Cytogenetic and Molecular Biomarkers;
- WP4 - Epigenetic Biomarkers;
- WP5 - Cell Culturing;
- WP6 - Bioinformatics;
- WP7 - Clinical Validation;
- WP8 - Multidisciplinary "Translational Team";
- WP9 - Networking;
News
Symposium zur Leukämie- und Lymphomdiagnostik
28.10.2011
From 12th to 15th October in Berlin the 19th. "Kieler" Symposium zur Leukämie- und Lymphomdiagnostik took place.
more »
9th National Congress in Haematology
25.05.2011
In October 27 - 30, 2011, at RIU Pravets Resort, in Pravets, will be held the 9th National Congress of BMSCTH.
more»
Up-to-date Status of the Scientific Issues in Bulgaria and Europe
The ultimate goal of translational medical research is to build a bridge spanning the gap between basic research and clinical practice.
Translational research in medicine is a branch of medical research that attempts to more directly connect basic research to patient care. Traditionally, basic research has been separated from the daily clinical practice of medicine. New diagnostic and prognostic tools and novel therapeutic approaches used to be developed independently of the clinic, and often disregarded shortly afterwards. Therefore, translational medicine typically refers to the "translation" of basic research into real benefits for real patients. The focus is on the functional link between the laboratory work and the practice at the patient's bedside. This is often called the "bench to bedside" definition. Some professionals consider translational medicine in a much broader context, referring to the patient environment driven research process, and the embrace of a more research driven clinical practice of medicine.
At a pan-European level the strong necessity for a faster and more efficient translation of research findings into the development of innovative strategies for the prevention, diagnosis and treatment of diseases which are of particular relevance for European member states and that have a high medical and economic burden has been recognized through international multidisciplinary initiatives:
- The European Advanced Translational Research Infrastructure (EATRIS) - www.eatris.eu,
- The European Clinical Research Infrastructures Network (ECRIN) - www.ecrin.org and
- The Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) - www.biobanks.eu.
The goal of those activities is to shorten the timelines from basic research discoveries to clinical benefits.
top of page
National Specialized Hospital for Active Treatment of Haematological Diseases
www.NSBALHZ.bg
Center of Excellence for Translational Research in Hematology
www.CETRH.org
This project is sponsored by National Science Fund, Ministry of Education and Science
Visual identity and development: lalev.com